This book provides up-to-date information on all aspects of radiotherapy for liver cancer, from the basic science to clinical practice. While demand for radiotherapy of liver cancer has been increasing, the guidance available to clinicians has remained limited. Radiotherapy of Liver Cancer aims to address this deficit on the basis of the best available evidence. The first two sections explain the relevant basic science and present detailed information on the available technologies and techniques, including the most recent advances. The radiotherapy strategies appropriate in different patient…mehr
This book provides up-to-date information on all aspects of radiotherapy for liver cancer, from the basic science to clinical practice. While demand for radiotherapy of liver cancer has been increasing, the guidance available to clinicians has remained limited. Radiotherapy of Liver Cancer aims to address this deficit on the basis of the best available evidence. The first two sections explain the relevant basic science and present detailed information on the available technologies and techniques, including the most recent advances. The radiotherapy strategies appropriate in different patient groups are then fully described, covering the use of ablative, adjuvant, neoadjuvant, and definitive radiotherapy, radiotherapy as a bridge to liver transplantation, and palliative radiotherapy. The final section addresses a range of specific issues of concern to the clinician. Radiotherapy of Liver Cancer will be an ideal reference for clinical radiation oncologists, radiation oncology residents, oncologists, and hepatologists. Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Jinsil Seong, MD, PhD, is a Professor in the Department of Radiation Oncology at Yonsei University Medical College in Seoul, Korea. She is also President of the Asia Pacific Primary Liver Cancer Expert (APPLE) Association and an Executive Board member for the Asian Oncologic Society. Professor Seong completed her medical training and PhD at Yonsei University. Prior to her current position, she was a Visiting Scientist in the Department of Experimental Radiotherapy at MD Anderson Cancer Center in Texas, USA. Professor Seong maintains active membership of numerous professional and academic societies. In 2019, she was awarded the Adrienne Wilson Liver Cancer Association's Blue Faery Award for Excellence in Liver Cancer Research for her pioneering work on radiotherapy for HCC. She was previously a recipient of the Cancer Prevention Award from the Korean Ministry of Health and Welfare and the Distinguished Scientific Award from the Korean Cancer Association. Professor Seong sits on the editorial board for the Journal of Hepatology and has published 312 papers, including 211 in international peer-reviewed journals. She is a frequent invited keynote speaker at academic conferences and educational events across Asia and the world.
Inhaltsangabe
Part 1 Basic Science in radiotherapy of liver cancer.- 1 Principle of Cancer Radiotherapy.- 2 Basic Science in radiotherapy of liver cancer - Radiobiology of liver.- 3 Imaging anatomy for the radiation oncologist.- 4 Functional assessment of liver for radiation oncologist.- 5 Antiviral Therapy in Liver Cancer.- Part 2 Technologies and techniques in radiotherapy of liver cancer.- 6 Technological advances in radiotherapy.- 7 Basics of ablative radiotherapy - The background knowledge necessary to practicing stereotactic body radiotherapy for hepatocellular carcinoma.- 8 Technologies and techniques in radiotherapy of liver cancer - Image Guided Radiotherapy.- 9 Technologies and techniques in radiotherapy of liver cancer - Particle beam radiotherapy.- 10 Internal radiotherapy using radionuclides.- Part 3 Radiotherapeutic strategies in liver cancer.- 11 Therapeutic guidelines from the perspective of radiation oncologists.- 12 Ablative RT for Early HCC.- 13 Transarterial Chemoembolization Plus External Beam Radiotherapy.- 14 Definitive radiotherapy for locally advanced hepatocellular carcinoma.- 15 Neoadjuvant RT converting to curative resection.- 16 Radiotherapeutic strategies in liver cancer - bridging therapy for liver transplantation.- 17 Palliative Radiotherapy.- Part 4 Specific issues.- 18 Multidisciplinary team approaches for the management of hepatocellular carcinoma.- 19 Response evaluation after radiotherapy.- 20 Liver hypertrophy following radiotherapy.- 21 Hepatic dysfunction following radiotherapy & management.- 22 Lymphopenia following radiotherapy for hepatocellular carcinoma.- 23 Specific issues - Perspectives of RT in immuno-oncology era.
Part 1 Basic Science in radiotherapy of liver cancer.- 1 Principle of Cancer Radiotherapy.- 2 Basic Science in radiotherapy of liver cancer - Radiobiology of liver.- 3 Imaging anatomy for the radiation oncologist.- 4 Functional assessment of liver for radiation oncologist.- 5 Antiviral Therapy in Liver Cancer.- Part 2 Technologies and techniques in radiotherapy of liver cancer.- 6 Technological advances in radiotherapy.- 7 Basics of ablative radiotherapy - The background knowledge necessary to practicing stereotactic body radiotherapy for hepatocellular carcinoma.- 8 Technologies and techniques in radiotherapy of liver cancer - Image Guided Radiotherapy.- 9 Technologies and techniques in radiotherapy of liver cancer - Particle beam radiotherapy.- 10 Internal radiotherapy using radionuclides.- Part 3 Radiotherapeutic strategies in liver cancer.- 11 Therapeutic guidelines from the perspective of radiation oncologists.- 12 Ablative RT for Early HCC.- 13 Transarterial Chemoembolization Plus External Beam Radiotherapy.- 14 Definitive radiotherapy for locally advanced hepatocellular carcinoma.- 15 Neoadjuvant RT converting to curative resection.- 16 Radiotherapeutic strategies in liver cancer - bridging therapy for liver transplantation.- 17 Palliative Radiotherapy.- Part 4 Specific issues.- 18 Multidisciplinary team approaches for the management of hepatocellular carcinoma.- 19 Response evaluation after radiotherapy.- 20 Liver hypertrophy following radiotherapy.- 21 Hepatic dysfunction following radiotherapy & management.- 22 Lymphopenia following radiotherapy for hepatocellular carcinoma.- 23 Specific issues - Perspectives of RT in immuno-oncology era.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826